Gamma Vaccines receives R&D tax credit.

Gamma vaccines receives an R&D Tax Credit for R&D conducted in FY2023 for the amount of $28,538.84.

Share this post

18/03/2025
Gamma Vaccines Changes its Status to a Public Company Limited by Shares
Gamma Vaccines announces that it has changed its status from a Private Company limited by shares to a…

Read article
05/10/2024
Gamma Vaccines acquires IP to develop NDV vaccine
Gamma Vaccines has signed a deed of assignment with the University of Adelaide for the rights to commercialise…

Read article
12/09/2024
Gamma vaccines signs international collaboration agreement.
Gamma vaccines has entered a collaboration agreement with Capricorn Technologies GmBH (Austria) and Aptum Adjuvants Ltd (UK) to…

Read article